- JP-listed companies
- 3-D Matrix,Ltd.
- Cash flow
3-D Matrix,Ltd. (7777) Cash flow
Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
| 2015/04 | 2016/04 | 2017/04 | 2018/04 | 2019/04 | 2020/04 | 2021/04 | 2022/04 | 2023/04 | 2024/04 | 2025/04 | |
| Depreciation & amortization | 53 | 44 | - | - | - | - | - | - | - | - | - |
| Cash from operations | -1,905 | -1,464 | -1,887 | -2,021 | -2,302 | -2,189 | -3,250 | -2,903 | -4,585 | -1,900 | -1,714 |
| Capital expenditures | -9 | -2 | -6 | -18 | -11 | -4 | -18 | -7 | -16 | -1 | -12 |
| Cash from investing | -126 | -345 | 69 | -82 | -137 | -113 | -160 | -80 | -82 | -30 | -33 |
| Cash from financing | 4,511 | 5 | 257 | 1,504 | 3,084 | 1,573 | 3,463 | 4,664 | 2,956 | 2,063 | 2,014 |
| Free cash flow | |||||||||||
| FCF margin (%) |